To explore whether p-STAT3 is involved in G6PD up-regulation in RCC, Real-time RT-PCR and Western blot were used to analyze the impact of p-STAT3 activators (interleukin 6, IL6) or inhibitors (STATTIC) on G6PD expression. This evidence concerns the gene STAT3 and renal cell carcinoma.